Liver & Biliary

Thank you making our sessions at the 42nd annual DDW® in Chicago, IL scientifically relevant and exciting! If you have specific feedback regarding speakers sponsored by Liver and Biliary (LB) section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2012 in San Diego. We are now accepting volunteers for DDW 2012 abstract review and topic/speaker suggestions. Please visit the Volunteer and Feedback Form to get involved.

This year the LB section accepted the majority of the abstracts submitted (91%). The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers.  The table below shows the change from last year:

LB Abstract Selection

2010

2011

Total Abstracts submitted

145

136

Accepted Abstracts

108

124

Oral Presentations

12

13

Posters

96

111

Posters of Distinction

11

13

The LB section sponsored Clinical and Translational Symposia, one State-of-the-Art Lecture, and two abstract based Research Fora. Our sessions were very well attended. The chart below outlines the sessions we sponsored at DDW 2011 and the number of people who attended the session. If you have feedback to share regarding any of these sessions please email Jennifer Gibson at AGA headquarters.

LB Sessions

 

Saturday, 5/7/2011

Duration

Attendance

Liver and Biliary Section Townhall Meeting

5:30 – 6:30 p.m.

unknown

Sunday, 5/8/2011

Research Forum:  Benign and Malignant Biliary Tract Disease

8:30 – 10 a.m.

54

State-of-the-Art Lecture:  The Dr. Charles S. Lieber Lecture: New Frontiers: Fatty Liver Disease and Metabolic Syndrome: Lessons from Genetics

10:30 – 11:30 a.m.

170

Clinical Symposium:  New Drugs for Liver Disease: Practical Considerations

2:15 – 3:45 p.m.

125

Monday, 5/9/2011

GRG Spring Symposium

8 – 10:30 a.m.

31

Research Forum:  Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapy

8:30 – 10 a.m.

110

Clinical Symposium:  Autoimmune Hepatitis New Drugs On The Block

2:15 – 3:45 p.m.

180

Translational Symposium:  Non-invasive Tests for Hepatic Fibrosis

4 – 5:30 a.m.

60


Each June, LB section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (LB descriptors may change as we go forward to DDW 2012.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Liver and Biliary were shared at DDW.

Descriptor Name

Abstracts Received

Abstract Review Chair

Abstract Reviewers

Clinical Biliary Tract Disorders, Stone Diseases and Stone Pathogenesis

33

Adam Slivka

Abdullah Al-Osaimi, John Martin, David Wang

Clinical Hepatitis: Etiology, Diagnosis, Management and Natural History

28

F. Fred Poordad

Robert Brown, Steven Flamm, Fredric Gordon, Nancy Reau

Liver and Biliary Carcinoma: Management, Etiology, Diagnosis and Natural History

19

Adam Slivka

Abdullah Al-Osaimi, John Martin, Neeraj Saxena

Complications of Liver Disease

18

Jamile Wakim-Fleming

Marco Bertolotti, Andres Cardenas, Karel Van Erpecum

Metabolic and Genetic Liver Disease, Including Alcoholic and Non-alcoholic Fatty Liver Diseases

24

Claudia Zein

Ariel Feldstein, Sean Koppe

Metabolism, Portal Hypertension and Vascular Diseases of the Liver

10

Claudia Zein

John Baillie, Louis Korman

 

Section leaders will review committee membership this summer for new abstract review committees to confirm the final composition for DDW 2012 committees.

If you are interested in serving as a reviewer for any of our abstract descriptors for DDW 2012, please fill out this form to volunteer. Please indicate the abstract descriptor for which you are interested in reviewing. You can also recommend any new descriptors for abstracts. LB section members interested in serving in this capacity are encouraged to contact us and volunteer to review abstracts. We are accepting volunteers through the end of July. You can join the LB section at any time.

In addition, we encourage you to submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please fill out this form to submit your suggestions to the AGA Institute by July 1, 2011.

Members interested in participating in the various activities of the section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.

Thank you for your continuing strong support of the LB section.

Sincerely,

Gregory J. Gores, MD, AGAF

Chair, LB Section, AGA Institute Council

Jorge A. Marrero, MD 

Vice-Chair, LB Section, AGA Institute Council